(Q46158813)

20 December 2017

title

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer (English)

1 reference

20 December 2017

author name string

V Ziller

1

1 reference

20 December 2017

M Kalder

2

1 reference

20 December 2017

U-S Albert

3

1 reference

20 December 2017

W Holzhauer

4

1 reference

20 December 2017

M Ziller

5

1 reference

20 December 2017

U Wagner

6

1 reference

20 December 2017

P Hadji

7

1 reference

20 December 2017

language of work or name

1 reference

15 January 2009

1 reference

20 December 2017

published in

Annals of Oncology

1 reference

20 December 2017

volume

20

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

431-436

1 reference

20 December 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Advances in adjuvant endocrine therapy for postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Practical guidance for the management of aromatase inhibitor-associated bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Non-adherence to endocrine therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Acceptance of adjuvant therapy and quality of life issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

The Menopause Rating Scale (MRS) scale: a methodological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Adherence to tamoxifen over the five-year course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN646

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN646

1 reference

20 December 2017

PubMed ID

19150950

1 reference

20 December 2017